Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
调节性 CD56(bright) 自然杀伤细胞介导 IL-2Rα 靶向治疗（达克珠单抗）在多发性硬化症中的免疫调节作用
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.0601335103
Bielekova Bibiana, Catalfamo Marta, Reichert-Scrivner Susan, Packer Amy, Cerna Magdalena, Waldmann Thomas A, McFarland Henry, Henkart Pierre A, Martin Roland
